dc.contributor.author | Saseen, Joseph J. | eng |
dc.contributor.author | Tweed, Elizabeth M. | eng |
dc.date.issued | 2006 | eng |
dc.description.abstract | Many combination drug therapies are effective in treating dyslipidemia. Compared with statin monotherapy, combinations that include ezetimibe (Zetia), a bile acid sequestrant, or niacin further lower low- density lipoprotein (LDL) cholesterol (strength of recommendation [SOR]: A), and increase the likelihood of attaining National Cholesterol Education Program (NCEP) LDL cholesterol goals (SOR: B). Adding ezetimibe to a bile acid sequestrant reduces LDL cholesterol (SOR: B). Fibrate or niacin added to statin monotherapy provide mixed lipid-modifying effects for combined dyslipidemia (SOR: A). | eng |
dc.identifier.uri | http://hdl.handle.net/10355/3512 | eng |
dc.language | English | eng |
dc.publisher | Family Physicians Inquiries Network | eng |
dc.relation.ispartofcollection | Clinical Inquiries, 2006 (MU) | eng |
dc.relation.ispartofcommunity | University of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network | eng |
dc.relation.ispartofseries | Journal of family practice, 55, no. 01 (January 2006) | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | eng |
dc.subject | combination drug therapy | eng |
dc.subject | statins | eng |
dc.subject | side effects | eng |
dc.subject.lcsh | Statins (Cardiovascular Agents) | eng |
dc.subject.lcsh | Lipids -- Metabolism -- Disorders | eng |
dc.subject.mesh | Dyslipidemias | eng |
dc.title | What are effective medication combinations for dyslipidemia? | eng |
dc.type | Article | eng |